Last Price
0.516
Today's Change
-0.011 (2.08%)
Day's Change
0.512 - 0.53
Trading Volume
287,212
Overview
Market Cap
15 Million
Shares Outstanding
29 Million
Avg Volume
1,314,579
Avg Price (50 Days)
0.40
Avg Price (200 Days)
0.34
PE Ratio
-1.40
EPS
-0.37
Earnings Announcement
23-Oct-2024
Previous Close
0.53
Open
0.53
Day's Range
0.512 - 0.53
Year Range
0.19 - 1.58
Trading Volume
287,217
Price Change Highlight
1 Day Change
-2.10%
5 Day Change
6.47%
1 Month Change
57.92%
3 Month Change
23.93%
6 Month Change
39.59%
Ytd Change
14.76%
1 Year Change
-12.47%
3 Year Change
-95.25%
5 Year Change
-84.21%
10 Year Change
-95.77%
Max Change
-99.02%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
2
3
4
CEO Morning Brief
Goldman Sachs Cuts Indian Stocks to Neutral on Slowing Growth
5
CEO Morning Brief
Apple’s Tim Cook Visits China, Talks Data Security With Minister
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
